Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional dyspepsia: evaluation and treatment.

Magnus Simrén1, Jan Tack

  • 1Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, University of Leuven, Herestraat 49, B-3000, Leuven, Belgium.

Gastroenterology Clinics of North America
|July 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

United European gastroenterology journal·2022
Same author

Editorial: refractory reflux sensitivity-A place for baclofen? Authors' reply.

Alimentary pharmacology & therapeutics·2022
Same author

Exploring the pathophysiology of LARS after low anterior resection for rectal cancer with high-resolution colon manometry.

Neurogastroenterology and motility·2022
Same author

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.

United European gastroenterology journal·2022
Same author

Clinical trial: a controlled trial of baclofen add-on therapy in PPI-refractory gastro-oesophageal reflux symptoms.

Alimentary pharmacology & therapeutics·2022
Same author

Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Trials·2022
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Functional dyspepsia is a common gastrointestinal disorder. Current treatments offer limited efficacy, highlighting the urgent need for novel and more effective therapeutic strategies.

Area of Science:

  • Gastroenterology
  • Digestive Health
  • Clinical Medicine

Background:

  • Functional dyspepsia (FD) is highly prevalent in primary care and gastroenterology settings.
  • Emerging research is refining understanding of FD pathophysiology and symptom correlations.
  • This evolving knowledge is crucial for developing future treatment options.

Purpose of the Study:

  • To review current understanding of functional dyspepsia.
  • To discuss the limitations of existing treatments for FD.
  • To emphasize the need for new therapeutic approaches.

Main Methods:

  • Literature review of recent advancements in functional dyspepsia research.
  • Analysis of current treatment guidelines and their efficacy.
  • Discussion of potential future therapeutic avenues.

Related Experiment Videos

Main Results:

  • Current empirical treatments like acid suppressors and prokinetics show limited effectiveness in managing FD symptoms.
  • Helicobacter pylori (H. pylori) treatment is recommended for uninvestigated dyspepsia but offers minimal symptomatic benefit for FD.
  • Antidepressants and psychological therapies may help refractory FD cases, but evidence for their efficacy is scarce.

Conclusions:

  • Functional dyspepsia management requires more effective treatment strategies.
  • The limited efficacy of current therapies underscores the urgent need for innovative interventions.
  • Further research into novel approaches is essential to improve patient outcomes in FD.